197 related articles for article (PubMed ID: 23877223)
1. Characterization of a multidrug-resistant chronic myeloid leukemia cell line presenting multiple resistance mechanisms.
Daflon-Yunes N; Pinto-Silva FE; Vidal RS; Novis BF; Berguetti T; Lopes RR; Polycarpo C; Rumjanek VM
Mol Cell Biochem; 2013 Nov; 383(1-2):123-35. PubMed ID: 23877223
[TBL] [Abstract][Full Text] [Related]
2. C-phycocyanin to overcome the multidrug resistance phenotype in human erythroleukemias with or without interaction with ABC transporters.
Fernandes E Silva E; Figueira FS; Cañedo AD; Machado KS; Salgado MTSF; Silva TK; Wagner EF; Mattozo FH; Lima ÉA; Sales-Neto JM; Ferreira VU; Comitre AA; Mascarenhas SR; Kalil SJ; Votto APS
Biomed Pharmacother; 2018 Oct; 106():532-542. PubMed ID: 29990841
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporine A enables vincristine-induced apoptosis during reversal of multidrug resistance phenotype in chronic myeloid leukemia cells.
de Souza PS; da Cunha Vasconcelos F; Silva LF; Maia RC
Tumour Biol; 2012 Aug; 33(4):943-56. PubMed ID: 22290425
[TBL] [Abstract][Full Text] [Related]
4. Sensitization of ABCB1 overexpressing cells to chemotherapeutic agents by FG020326 via binding to ABCB1 and inhibiting its function.
Dai CL; Liang YJ; Chen LM; Zhang X; Deng WJ; Su XD; Shi Z; Wu CP; Ashby CR; Akiyama S; Ambudkar SV; Chen ZS; Fu LW
Biochem Pharmacol; 2009 Aug; 78(4):355-64. PubMed ID: 19410561
[TBL] [Abstract][Full Text] [Related]
5. Arsenic induces apoptosis of multidrug-resistant human myeloid leukemia cells that express Bcr-Abl or overexpress MDR, MRP, Bcl-2, or Bcl-x(L).
Perkins C; Kim CN; Fang G; Bhalla KN
Blood; 2000 Feb; 95(3):1014-22. PubMed ID: 10648417
[TBL] [Abstract][Full Text] [Related]
6. Multidrug resistance in chronic myeloid leukaemia: how much can we learn from MDR-CML cell lines?
Rumjanek VM; Vidal RS; Maia RC
Biosci Rep; 2013 Nov; 33(6):. PubMed ID: 24070327
[TBL] [Abstract][Full Text] [Related]
7. Reversal effect of ST6GAL 1 on multidrug resistance in human leukemia by regulating the PI3K/Akt pathway and the expression of P-gp and MRP1.
Ma H; Cheng L; Hao K; Li Y; Song X; Zhou H; Jia L
PLoS One; 2014; 9(1):e85113. PubMed ID: 24454800
[TBL] [Abstract][Full Text] [Related]
8. Effects of imatinib and 5-bromotetrandrine on the reversal of multidrug resistance of the K562/A02 cell line.
Chen BA; Shan XY; Chen J; Xia GH; Xu WL; Schmit M
Chin J Cancer; 2010 Jun; 29(6):591-5. PubMed ID: 20507731
[TBL] [Abstract][Full Text] [Related]
9. Effect of magnetic nanoparticles of Fe3O4 and 5-bromotetrandrine on reversal of multidrug resistance in K562/A02 leukemic cells.
Cheng J; Wu W; Chen BA; Gao F; Xu W; Gao C; Ding J; Sun Y; Song H; Bao W; Sun X; Xu C; Chen W; Chen N; Liu L; Xia G; Li X; Wang X
Int J Nanomedicine; 2009; 4():209-16. PubMed ID: 19918367
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic effect of 6-Shogaol in Imatinib sensitive and resistant K562 cells.
Ozkan T; Hekmatshoar Y; Pamuk H; Ozcan M; Yaman G; Yagiz GC; Akdemir C; Sunguroglu A
Mol Biol Rep; 2021 Feb; 48(2):1625-1631. PubMed ID: 33515349
[TBL] [Abstract][Full Text] [Related]
11. Olmutinib Reverses Doxorubicin Resistance in ETS1-Overexpressing Leukemia Cells.
Zhong J; Zhang J; Yu X; Zhang X; Dian L
Med Sci Monit; 2020 Aug; 26():e924922. PubMed ID: 32830792
[TBL] [Abstract][Full Text] [Related]
12. The novel BCR-ABL and FLT3 inhibitor ponatinib is a potent inhibitor of the MDR-associated ATP-binding cassette transporter ABCG2.
Sen R; Natarajan K; Bhullar J; Shukla S; Fang HB; Cai L; Chen ZS; Ambudkar SV; Baer MR
Mol Cancer Ther; 2012 Sep; 11(9):2033-44. PubMed ID: 22778153
[TBL] [Abstract][Full Text] [Related]
13. Novel pharmacological approach for the prevention of multidrug resistance (MDR) in a human leukemia cell line.
Gupta SK; Singh P; Chhabra R; Verma M
Leuk Res; 2021 Oct; 109():106641. PubMed ID: 34144313
[TBL] [Abstract][Full Text] [Related]
14. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J
Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682
[TBL] [Abstract][Full Text] [Related]
15. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells.
Liu W; Meng Q; Sun Y; Wang C; Huo X; Liu Z; Sun P; Sun H; Ma X; Liu K
Cell Physiol Biochem; 2018; 51(4):1616-1631. PubMed ID: 30497065
[TBL] [Abstract][Full Text] [Related]
16. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway.
Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ
Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633
[TBL] [Abstract][Full Text] [Related]
17. Multidrug resistance in tumour cells: characterization of the multidrug resistant cell line K562-Lucena 1.
Rumjanek VM; Trindade GS; Wagner-Souza K; de-Oliveira MC; Marques-Santos LF; Maia RC; Capella MA
An Acad Bras Cienc; 2001 Mar; 73(1):57-69. PubMed ID: 11246270
[TBL] [Abstract][Full Text] [Related]
18. B4GALT family mediates the multidrug resistance of human leukemia cells by regulating the hedgehog pathway and the expression of p-glycoprotein and multidrug resistance-associated protein 1.
Zhou H; Ma H; Wei W; Ji D; Song X; Sun J; Zhang J; Jia L
Cell Death Dis; 2013 Jun; 4(6):e654. PubMed ID: 23744354
[TBL] [Abstract][Full Text] [Related]
19. Selective Cytotoxicity of Piperine Over Multidrug Resistance Leukemic Cells.
Quarti J; Torres DNM; Ferreira E; Vidal RS; Casanova F; Chiarini LB; Fialho E; Rumjanek VM
Molecules; 2021 Feb; 26(4):. PubMed ID: 33578817
[TBL] [Abstract][Full Text] [Related]
20. Wnt/β-catenin pathway regulates ABCB1 transcription in chronic myeloid leukemia.
Corrêa S; Binato R; Du Rocher B; Castelo-Branco MT; Pizzatti L; Abdelhay E
BMC Cancer; 2012 Jul; 12():303. PubMed ID: 22823957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
